McDonald, John R <br/><br/>
Selective chemokine receptor-targeted depletion of pathological cells as a therapeutic strategy for inflammatory, allergic and autoimmune diseases.  [electronic resource] 

 -  Recent patents on inflammation & allergy drug discovery  Nov 2009 
 - 177-87 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1872-213X 
<br/><br/><label>Standard No.: </label>10.2174/187221309789257423  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Bispecific--therapeutic use<br/>Autoimmune Diseases--drug therapy<br/>Bacterial Toxins--genetics<br/>Chemokines--genetics<br/>Cytotoxicity, Immunologic<br/>Humans<br/>Hypersensitivity--drug therapy<br/>Leukocyte Reduction Procedures<br/>Patents as Topic<br/>Receptors, Chemokine--immunology<br/>Recombinant Fusion Proteins--genetics